Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 04 entities : Johnson & johnson save search
Xencor and Janssen Unite Again in Second Bispecific Antibodies Agreement
Published: 2021-10-04 (Crawled : 22:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
antibody
Bentley University Announces Vaccination Requirement for Home Indoor Athletic Events
Published: 2021-10-04 (Crawled : 20:00) - prnewswire.com
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.4%
H: 0.78%
C: -0.18%
vaccine
Novavax Announces Leadership Appointment and Updates
Published: 2021-10-04 (Crawled : 20:00) - prnewswire.com
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: 0.4%
H: 0.78%
C: -0.18%
NVAX | $4.09 3.02% 2.93% 2.3M
|
Health Technology
|
| O: 1.81%
H: 2.04%
C: -6.34%
COVID-19 Update: J&J to Request Booster Authorization, Merck Antiviral Review a Priority
Published: 2021-10-04 (Crawled : 17:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
covid antiviral authorized covid-19
Global Molecular Diagnostics Markets Analysis & Forecasts, 2016-2020 & 2021-2026 with COVID-19 Impact Insights
Published: 2021-10-04 (Crawled : 16:00) - prnewswire.com
TMO | News | $548.38 0.66% 0.29% 1.5M
|
Health Technology
|
| O: -0.2%
H: 0.52%
C: -0.45%
QGEN | $41.22 3.05% 0.0% 1.2M
|
Health Technology
|
| O: -0.02%
H: 0.26%
C: -0.69%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
DHR | $236.08 0.24% 0.0% 2.8M
|
Health Technology
|
| O: -0.19%
H: 0.62%
C: -1.05%
BDX | $233.88 -0.1% 0.0% 770K
|
Health Technology
|
| O: -0.44%
H: 1.51%
C: -1.26%
ABT | News | $107.07 -0.2% 0.0% 4.9M
|
Health Technology
|
| O: -0.51%
H: 0.82%
C: -0.93%
QGEN | $41.22 3.05% 0.0% 1.2M
|
Health Technology
|
| O: -0.02%
H: 0.26%
C: -0.69%
covid molecular diagnostics molecular diagnostics diagnostic
Clinical Catch-Up: September 27-October 1
Published: 2021-10-04 (Crawled : 14:15) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.54%
H: 0.77%
C: 0.17%
New Analysis Presented by Janssen at United European Gastroenterology Week (UEGW) Demonstrates Long-Term Safety Profile for STELARA® (ustekinumab) in Older Patients Across Approved Indications
Published: 2021-10-04 (Crawled : 13:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
europe order
Adamis Announces Appointment of Meera Desai, Ph.D., to Board of Directors
Published: 2021-10-04 (Crawled : 12:00) - globenewswire.com
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
NKTR | News | $1.37 10.48% 9.49% 2M
|
Health Technology
|
| O: 2.74%
H: 1.58%
C: -1.58%
ADMP | $0.7751 0.86% 2.6% 120K
|
Health Technology
|
| O: 3.98%
H: 3.96%
C: 2.97%
Xencor Enters Global Collaboration and License Agreement With Janssen to Advance Plamotamab and XmAb CD28 Bispecific Antibody Combinations for the Treatment of Patients With B-Cell Malignancies
Published: 2021-10-04 (Crawled : 12:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
XNCR | $18.19 -1.03% -1.04% 490K
|
Health Technology
|
| O: 2.87%
H: 5.64%
C: 5.37%
treatment collaboration antibody license t-cell
Active Pharmaceutical Ingredient (API) Market to Cross $357,005.7 Million Value by 2030, says P&S Intelligence
Published: 2021-10-04 (Crawled : 10:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510
|
Health Technology
|
| O: 1.49%
H: 0.0%
C: -0.77%
AZNCF | News | $136.2 -4.19% 1.7K
|
Health Technology
|
| O: 6.28%
H: 0.0%
C: -0.2%
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: 0.0%
TEVA | $12.88 0.16% 0.0% 7.9M
|
Health Technology
|
| O: -1.95%
H: 2.51%
C: 0.73%
TAK | News | $13.36 0.91% -0.52% 1.6M
|
Health Technology
|
| O: -0.28%
H: 0.49%
C: -1.16%
NVS | News | $95.12 0.81% -1.18% 2.4M
|
Health Technology
|
| O: 0.83%
H: 1.0%
C: 0.15%
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
GSK | News | $40.59 2.11% -0.36% 3.8M
|
Health Technology
|
| O: 0.1%
H: 1.02%
C: 0.37%
LLY | News | $731.33 0.69% 0.0% 2.3M
|
Health Technology
|
| O: -1.53%
H: 1.05%
C: -1.29%
BMY | $49.14 0.43% 0.0% 7.9M
|
Health Technology
|
| O: 0.13%
H: 1.05%
C: -0.79%
ABBV | News | $167.89 0.89% 0.0% 5.6M
|
Health Technology
|
| O: 0.71%
H: 1.25%
C: -0.1%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 0.54%
H: 0.77%
C: 0.17%
AZN | News | $70.12 2.29% 2.24% 4.8M
|
Health Technology
|
| O: 1.28%
H: 0.83%
C: 0.82%
Addex to Present at the 10th International Meeting on Metabotropic Glutamate Receptors
Published: 2021-10-04 (Crawled : 06:00) - globenewswire.com
JNJ | News | $149.12 0.82% 0.0% 9.3M
|
Health Technology
|
| O: -0.98%
H: 0.63%
C: -0.48%
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.